Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial
Head and neck tumors (HNT)（2018）
摘要
.
更多查看译文
关键词
lenvatinib,radioiodine-refractory differentiated cancer,thyroid
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要